EU fines Teva and Cephalon €60.5m for 'pay for delay' scheme

The European Union has fined Teva and its neurology unit Cephalon €60.5 million for an elaborate “pay for delay” scheme that prevented cheaper generic competition for its sleep disorder dru

FTC clears Mylan merger with Pfizer’s Upjohn – with conditio...

Mylan’s $12 billion takeover of Pfizer’s Upjohn unit has been cleared by the US authorities, but on the condition that the two companies divest various generic drug products.

Trump's boasting overshadows supply deal for COVID-19 drugs

President Trump’s big agreement with a new US drugmaker to supply drugs for COVID-19 has been overshadowed by his admission he is taking hydroxychloroquine as a preventive meas

Antitrust delay scuppers Novartis’ $1bn generics sale to Aur...

Amarin hit hard as generics loom for fish oil drug Vascepa

Biogen claims victory in patent dispute with Mylan over MS d...